Jiangsu Nhwa Pharmaceutical Co., Ltd.
002262
Rangering i aksjer
#4619
Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical... Jiangsu Nhwa Pharmaceutical Co., LTD operates as a global pharmaceutical entity, focusing on the research, production, and sale of treatments for the central nervous system, along with cardiovascular and cerebrovascular ailments. Its comprehensive product line includes therapeutics for anesthesia, psychiatry, and neurological disorders. Additionally, the company is a supplier of Active Pharmaceutical Ingredients (APIs), specifically for central nervous system, anesthetic, and sedative applications, among others. The firm was established in 1978 and is based in Xuzhou, China.
Aksjekurs
$3.20
Markedsverdi
$3.24B
Endring (1 dag)
-2.37%
Endring (1 år)
-11.64%
Land
CN
Handel Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Kategori
Healthcare
Aksjeprishistorikk for Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)
Høyeste sluttskurs: $3.15 den 2026-10-01
Laveste sluttskurs: $0.24 den 2008-07-01
Laveste sluttskurs: $0.24 den 2008-07-01
Aksjeprishistorikk for Jiangsu Nhwa Pharmaceutical Co., Ltd. fra 2008 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | -7.86% |
| 2025 | 0.84% |
| 2024 | -6.47% |
| 2023 | 21.41% |
| 2022 | 29.91% |
| 2021 | -10.52% |
| 2020 | 65.99% |
| 2019 | 11.29% |
| 2018 | -34.33% |
| 2017 | 17.11% |
| 2016 | -13.62% |
| 2015 | 27.78% |
| 2014 | 21.35% |
| 2013 | 73.55% |
| 2012 | 33.53% |
| 2011 | -15.50% |
| 2010 | 63.69% |
| 2009 | 105.21% |
| 2008 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
